Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$14.83 - $26.72 $127,523 - $229,765
-8,599 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$9.77 - $24.6 $84,012 - $211,535
8,599 New
8,599 $212,000
Q3 2019

Nov 14, 2019

SELL
$10.17 - $13.86 $163,523 - $222,854
-16,079 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$11.43 - $15.12 $183,782 - $243,114
16,079 New
16,079 $202,000
Q4 2017

Feb 14, 2018

SELL
$11.55 - $20.1 $234,580 - $408,231
-20,310 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$12.7 - $19.25 $257,937 - $390,967
20,310
20,310 $387,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.